Peterson Kristine
SEC insider (Form 3/4/5 filer). CIK 0001508596. Director at Mineralys Therapeutics, Inc. (MLYS) and 3 other issuers. 7 reported Form 4/5 transactions since Sep 2024; latest on Oct 19, 2026. Located in RADNOR, PA.
Companies Peterson Kristine has filed insider reports for
- Mineralys Therapeutics, Inc. (MLYS): Director
- ArriVent BioPharma, Inc. (AVBP): Director
- Immunocore Holdings plc (IMCR): Director
- ENANTA PHARMACEUTICALS INC (ENTA): Director
Peterson Kristine
CIK: 0001508596
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Oct 19, 2026MLYS
Mineralys Therapeutics, Inc.
AwardDirect12.4K shares- - Jun 18, 2026AVBP
ArriVent BioPharma, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
13.6K shares- - May 27, 2026IMCR
Immunocore Holdings plc
AwardDirectShare Option (Right to Buy)
27.5K shares- - Mar 11, 2026ENTA
ENANTA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
20K shares- - Jun 18, 2025AVBP
ArriVent BioPharma, Inc.
AwardDirectNon-Qualified Stock Option (right to buy)
15.5K shares- - May 15, 2025IMCR
Immunocore Holdings plc
AwardDirectShare Option (Right to Buy)
26.2K shares- - Mar 13, 2025ENTA
ENANTA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
15.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 19, 2026 |  MLYS Mineralys Therapeutics, Inc. | Award | 12,400 | - | $0 | Direct |
| Jun 18, 2026 |  AVBP ArriVent BioPharma, Inc. | Award Non-Qualified Stock Option (right to buy) | 13,562 | - | - | Direct |
| May 27, 2026 |  IMCR Immunocore Holdings plc | Award Share Option (Right to Buy) | 27,492 | - | - | Direct |
| Mar 11, 2026 |  ENTA ENANTA PHARMACEUTICALS INC | Award Stock Option (right to buy) | 20,000 | - | - | Direct |
| Jun 18, 2025 | AVBP ArriVent BioPharma, Inc. | Award Non-Qualified Stock Option (right to buy) | 15,502 | - | - | Direct |
| May 15, 2025 | IMCR Immunocore Holdings plc | Award Share Option (Right to Buy) | 26,198 | - | - | Direct |
| Mar 13, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Award Stock Option (right to buy) | 15,700 | - | - | Direct |
1-7 of 7 transactions